{
    "clinical_study": {
        "@rank": "115883", 
        "acronym": "PERASTUN", 
        "arm_group": [
            {
                "arm_group_label": "Aspirin", 
                "arm_group_type": "Experimental", 
                "description": "Aspirin 160 mg per day"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo 160 mg per day"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to test the efficacy of low-dose aspirin (160 mg/day), given\n      bedtime and started early during pregnancy (\u2264 15 +6 weeks of gestation) in nulliparous\n      pregnant women selected as \"high-risk\" by the presence of a bilateral uterine artery notch\n      and/or bilateral uterine artery PI \u2265 1.7 during the first trimester ultrasound scan (11-13+6\n      weeks), to prevent the occurrence of pre-eclampsia or small for gestational age at birth."
        }, 
        "brief_title": "Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pre-eclampsia", 
            "Intra-uterine Growth Restriction"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Eclampsia", 
                "Fetal Growth Retardation", 
                "Pre-Eclampsia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 years\n\n          -  Nulliparous (no previous pregnancy \u2265 22 SA)\n\n          -  Singleton pregnancy\n\n          -  Gestational age \u2264 15 +6 weeks\n\n          -  Bilateral uterine artery notch (grade \u2265 2) and/or bilateral uterine artery PI \u2265 1.7\n             during first trimester ultrasound (CRL between 45 and 84 mm)\n\n          -  Maternal informed consent obtained\n\n          -  Affiliated to social security system\n\n        Exclusion Criteria:\n\n          -  Women considering voluntary pregnancy termination (\u2264 14 weeks)\n\n          -  Pre-existing (maternal) indication for premature delivery before 37 weeks\n\n          -  Fetal condition detected during the first trimester scan (fetal malformation or\n             nuchal translucency \u2265 95th percentile)\n\n          -  Women under anticoagulation\n\n          -  Allergy or hypersensitivity to Kardegic\u00ae or one of its constituents\n\n          -  Secondary hemostasis disorder responsible for bleeding or risk of bleeding\n\n          -  Peptic ulcer under evolution\n\n          -  Lupus or antiphospholipid syndrome"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Months"
        }, 
        "enrollment": {
            "#text": "4972", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01729468", 
            "org_study_id": "PHRN08-FP/PERASTUN", 
            "secondary_id": [
                "2011-003536-30", 
                "2012-R8", 
                "A120316-72", 
                "912140"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Aspirin", 
                "description": "Aspirin, 160 mg per day until 34 weeks of gestation", 
                "intervention_name": "Aspirin", 
                "intervention_type": "Drug", 
                "other_name": "Aspirin"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo, 160 mg per day until 34 weeks of gestation", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Placebo"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Low Dose Acetylsalicylic Acid", 
            "Prevention", 
            "Pre-eclampsia", 
            "Intra-uterine Growth Restriction", 
            "Primiparous Women", 
            "Bilateral Uterine Artery Notches", 
            "First Quarter"
        ], 
        "lastchanged_date": "October 1, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Dominique Dallay, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33000"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obst\u00e9trique, Groupe Hospitalier Pellegrin, CHRU de Bordeaux"
                }, 
                "investigator": {
                    "last_name": "Dominqiue Dallay, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Muriel Doret, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bron", 
                        "country": "France", 
                        "zip": "69677"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obst\u00e9trique, HFME, Hospices Civils de Lyon"
                }, 
                "investigator": {
                    "last_name": "Muriel Doret, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Guillaume Benoist, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14033"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obst\u00e9trique, H\u00f4pital C\u00f4te de Nacre, CHU de Caen"
                }, 
                "investigator": {
                    "last_name": "Guillaume Benoist, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Didier Lemery, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63003"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obst\u00e9trique, H\u00f4pital d'Estaing, CHU de Clermont-Ferrand"
                }, 
                "investigator": {
                    "last_name": "Didier Lemery, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Georges Haddad, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "La Chauss\u00e9e St Victor", 
                        "country": "France", 
                        "zip": "41260"
                    }, 
                    "name": "Cabinet Mosa\u00efque Sant\u00e9"
                }, 
                "investigator": {
                    "last_name": "Georges Haddad, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jean Pierre Bernard, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Le Chesnay", 
                        "country": "France", 
                        "zip": "78150"
                    }, 
                    "name": "Centre Europ\u00e9en de Diagnostic et d'Exploration de la Femme"
                }, 
                "investigator": {
                    "last_name": "Jean Pierre Bernard, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "V\u00e9ronique Houfflin-Debarge, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Service de Gy\u00e9n\u00e9cologie-Obst\u00e9trique, H\u00f4pital Jeanne de Flandre, CHRU de Lille"
                }, 
                "investigator": {
                    "last_name": "V\u00e9ronique Houfflin-Debarge, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Anaig Flandrin, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obst\u00e9trique, H\u00f4pital Arnaud de Villeneuve, CHRU de Montpellier"
                }, 
                "investigator": {
                    "last_name": "Anaig Flandrin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Norbert Winer, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Service de gyn\u00e9cologie-obst\u00e9trique, H\u00f4pital M\u00e8re-Enfant, CHRU de Nantes"
                }, 
                "investigator": {
                    "last_name": "Norbert Winer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Pierre Mar\u00e8s, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "N\u00eemes", 
                        "country": "France", 
                        "zip": "30029"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obst\u00e9trique, H\u00f4pital Car\u00e9meau, CHRU de N\u00eemes"
                }, 
                "investigator": {
                    "last_name": "Pierre Mar\u00e8s, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Pascal Megier, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Orl\u00e9ans", 
                        "country": "France", 
                        "zip": "45032"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obst\u00e9trique, H\u00f4pital Porte Madeleine, CHR d'Orl\u00e9ans"
                }, 
                "investigator": {
                    "last_name": "Pascal Megier, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Yves Ville, Md-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75014"
                    }, 
                    "name": "Centre de d\u00e9pistage PRIMA FACIE, H\u00f4pital Necker, APHP"
                }, 
                "investigator": {
                    "last_name": "Yves Ville, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christophe Vayssi\u00e8re, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31059"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obst\u00e9trique, H\u00f4pital Paule de Viguier, CHU de Toulouse"
                }, 
                "investigator": {
                    "last_name": "Christophe Vayssi\u00e8re, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Franck Perrotin, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37044"
                    }, 
                    "name": "Service de Gyn\u00e9cologie-Obstetrique, Centre Olympe de Gouges, CHRU de Tours"
                }, 
                "investigator": {
                    "last_name": "Franck Perrotin, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers", 
        "other_outcome": [
            {
                "measure": "Mode of delivery (vaginal or cesarean)", 
                "safety_issue": "No", 
                "time_frame": "women will be followed for the duration of pregnancy, an expected average of 25 to 30 weeks"
            }, 
            {
                "measure": "Mode of anesthesia for delivery", 
                "safety_issue": "No", 
                "time_frame": "women will be followed for the duration of pregnancy, an expected average of 25 to 30 weeks"
            }
        ], 
        "overall_contact": {
            "email": "franck.perrotin@med.univ-tours.fr", 
            "last_name": "Franck PERROTIN, MD-PhD", 
            "phone": "+33(0)2.47.47.47.39"
        }, 
        "overall_contact_backup": {
            "email": "yoann.desvignes@med.univ-tours.fr", 
            "last_name": "Yoann DESVIGNES", 
            "phone": "+33(0)2.47.47.46.32"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Tours", 
            "last_name": "Franck PERROTIN, MD-PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Preeclampsia (diagnosed per ACOG criteria) and small for gestational age at birth (\u22645th percentile on customized growth curves)", 
            "safety_issue": "No", 
            "time_frame": "women will be followed for the duration of pregnancy and postpartum, an expected average of 26 to 31 weeks"
        }, 
        "reference": [
            {
                "PMID": "22986844", 
                "citation": "Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Combined Screening for Preeclampsia and Small for Gestational Age at 11-13 Weeks. Fetal Diagn Ther. 2012 Sep 13. [Epub ahead of print]"
            }, 
            {
                "PMID": "23004922", 
                "citation": "Ayala DE, Ucieda R, Hermida RC. Chronotherapy With Low-Dose Aspirin for Prevention of Complications in Pregnancy. Chronobiol Int. 2012 Sep 24. [Epub ahead of print]"
            }, 
            {
                "PMID": "18634131", 
                "citation": "Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008 Aug;32(2):138-46."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01729468"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Small for gestational age at birth (\u22645th percentile on customized growth curves)", 
                "safety_issue": "No", 
                "time_frame": "women will be followed for the duration of pregnancy, an expected average of 25 to 30 weeks"
            }, 
            {
                "measure": "Pre-eclampsia (ACOG criteria) requiring delivery before 34 weeks", 
                "safety_issue": "No", 
                "time_frame": "women will be followed for the duration of pregnancy and postpartum, an expected average of 26 to 31 weeks"
            }, 
            {
                "measure": "Severe pre-eclampsia (ACOG criteria)", 
                "safety_issue": "No", 
                "time_frame": "women will be followed for the duration of pregnancy and postpartum, an expected average of 26 to 31 weeks"
            }, 
            {
                "measure": "Perinatal death (22 weeks of gestation to 7 days postnatal)", 
                "safety_issue": "No", 
                "time_frame": "women will be followed for the duration of pregnancy and postpartum, an expected average of 26 to 31 weeks"
            }, 
            {
                "measure": "Pre-eclampsia (ACOG criteria)", 
                "safety_issue": "No", 
                "time_frame": "women will be followed for the duration of pregnancy and postpartum, an expected average of 26 to 31 weeks"
            }, 
            {
                "measure": "Adverse effects of treatment", 
                "safety_issue": "No", 
                "time_frame": "women will be followed for the duration of pregnancy and postpartum, an expected average of 26 to 31 weeks"
            }
        ], 
        "source": "University Hospital, Tours", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Tours", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}